Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Dasiglucagon Details
Congenital Hyperinsulinism

NDA

Submission

Glepaglutide Details
Short bowel syndrome

Phase 3

Data readout

Dasiglucagon Details
Type 1 diabetes

Phase 3

Update

Dasiglucagon Details
Type 1 diabetes

Phase 2

Data readout

Phase 2

Data readout

Phase 2

Data readout

BI 456906 (GLP-1/glucagon dual agonist) Details
Obesity, Non-alcoholic steatohepatitis

Phase 2

Update

Phase 1

Data readout

Phase 1

Initiation